Home

навременен Треперете облекчение non ligand estrogen pathway nf kappa fulvestrant артерия Инфрачервен конски сили

Estrogen receptor signaling as a target for novel breast cancer  therapeutics - ScienceDirect
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for  Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of  Medicinal Chemistry
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in  Hormone-Dependent Cancers | HTML
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML

Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen  Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase |  PLOS ONE
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on  Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling.,Cell Chemical Biology - X-MOL
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL

Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate  Immobilization and Degradation of Estrogen Receptor-α* - Journal of  Biological Chemistry
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Estrogen receptor-α signaling in post-natal mammary development and breast  cancers | SpringerLink
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

EREs).
EREs).

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor  Malignancy | HTML
IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor Malignancy | HTML

Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE

Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α  Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist  XCT790* - Journal of Biological Chemistry
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry

Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor  microenvironment - Abstract - Europe PMC
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC

Estrogen receptor functional domains and signal transduction schemes.... |  Download Scientific Diagram
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram

Distinct mechanisms of resistance to fulvestrant treatment dictate level of  ER independence and selective response to CDK inhibitors in metastatic  breast cancer | Breast Cancer Research | Full Text
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text